Hospital administrators cannot reduce kidney care costs despite massive capital investments in interventions

Hospital finance teams and nephrology departments are investing heavily in kidney care programs and technologies, yet these investments are failing to translate into measurable reductions in hospital costs or patient outcomes. Current intervention strategies are misaligned with actual cost drivers, leaving administrators unable to justify continued spending or demonstrate ROI to boards and stakeholders.